medmix Future Growth

Future criteria checks 3/6

medmix is forecast to grow earnings and revenue by 60.5% and 7.3% per annum respectively. EPS is expected to grow by 60.5% per annum. Return on equity is forecast to be 13.2% in 3 years.

Key information

60.5%

Earnings growth rate

60.5%

EPS growth rate

Medical Equipment earnings growth	17.5%
Revenue growth rate	7.3%
Future return on equity	13.2%
Analyst coverage	Low
Last updated	02 Jul 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:MDMX.F - Analysts future estimates and past financials data (CHF Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	605	70	N/A	N/A	1
12/31/2025	563	52	41	N/A	2
12/31/2024	518	34	50	N/A	2
12/31/2023	487	0	3	56	N/A
9/30/2023	481	5	-3	47	N/A
6/30/2023	475	10	-9	37	N/A
3/31/2023	476	11	0	42	N/A
12/31/2022	477	12	9	48	N/A
9/30/2022	478	21	22	57	N/A
6/30/2022	480	31	36	66	N/A
3/31/2022	468	37	46	76	N/A
12/31/2021	457	44	55	87	N/A
9/30/2021	435	36	56	90	N/A
6/30/2021	414	28	57	94	N/A
3/31/2021	382	19	32	72	N/A
12/31/2020	351	10	8	51	N/A
12/31/2019	421	25	53	89	N/A
12/31/2018	454	52	64	94	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDMX.F's forecast earnings growth (60.5% per year) is above the savings rate (2.4%).

Earnings vs Market: MDMX.F's earnings (60.5% per year) are forecast to grow faster than the US market (14.7% per year).

High Growth Earnings: MDMX.F's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MDMX.F's revenue (7.3% per year) is forecast to grow slower than the US market (8.7% per year).

High Growth Revenue: MDMX.F's revenue (7.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MDMX.F's Return on Equity is forecast to be low in 3 years time (13.2%).